Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation
Authors
Keywords
-
Journal
International Journal of Endocrinology
Volume 2014, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2014-04-11
DOI
10.1155/2014/617638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness and Long-Term Safety of Thiazolidinediones and Metformin in Renal Transplant Recipients
- (2013) Binumol Kurian et al. Endocrine Practice
- Novel views on new-onset diabetes after transplantation: development, prevention and treatment
- (2013) M. Hecking et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Vildagliptin and Pioglitazone in Patients With Impaired Glucose Tolerance After Kidney Transplantation
- (2013) Johannes Werzowa et al. TRANSPLANTATION
- Potential Risks of Metformin in Transplant Patients
- (2012) J. L. Larsen AMERICAN JOURNAL OF TRANSPLANTATION
- Clinical Trials for Treatment of NODAT
- (2012) Adnan Sharif et al. TRANSPLANTATION
- Bile Acids Aspiration Reduces Survival in Lung Transplant Recipients with BOS Despite Azithromycin
- (2011) V. Mertens et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Should Metformin Be Our Antiglycemic Agent of Choice Post-transplantation?
- (2011) A. Sharif AMERICAN JOURNAL OF TRANSPLANTATION
- Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
- (2011) K. J. Lipska et al. DIABETES CARE
- Sitagliptin: a review
- (2011) Sreevidya Subbarayan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Sitagliptin Therapy in Kidney Transplant Recipients With New-Onset Diabetes After Transplantation
- (2011) James T. Lane et al. TRANSPLANTATION
- Successful Long-Term Use of Sitagliptin for the Treatment of New-Onset Diabetes Mellitus After Solid Organ Transplantation: A Case Report
- (2011) N.R. Pinelli et al. TRANSPLANTATION PROCEEDINGS
- Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
- (2010) A. D. Dobrian et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
- (2010) D. Williams-Herman et al. DIABETES OBESITY & METABOLISM
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals
- (2010) A. Zanchi et al. DIABETOLOGIA
- Risk Factors and Outcomes Associated With Posttransplant Diabetes Mellitus in Kidney Transplant Recipients
- (2010) E.S. Siraj et al. TRANSPLANTATION PROCEEDINGS
- A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation
- (2010) Michael Haidinger et al. Trials
- Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
- (2009) P. Aschner et al. DIABETES OBESITY & METABOLISM
- Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes
- (2009) James Mu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Posttransplant Diabetes Mellitus and Acute Rejection: Impact on Kidney Transplant Outcome
- (2009) Arthur J. Matas et al. TRANSPLANTATION
- Prediabetes in Patients Receiving Tacrolimus in the First Year After Kidney Transplantation: A Prospective and Multicenter Study
- (2009) Esteban Porrini et al. TRANSPLANTATION
- Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
- (2008) O. Johnston et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dyslipidemia Can Be Controlled in Diabetic as Well as Nondiabetic Recipients After Kidney Transplant
- (2008) Vijay Shivaswamy et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now